LPCN Lipocine Inc.: institutional ownership and insider trading
36 funds reported holding $9.41M of Lipocine Inc. in their latest 13F filings; in Q2 2026 funds net sold $353K, with 4 new positions and 15 funds selling out; over the last 12 months insiders bought $517K and sold $0 on the open market.
Famous investors holding LPCN
- Two Sigma (Two Sigma Investments): $217K, 0.0% of the portfolio
- Ken Griffin (Citadel Advisors): $208K, 0.0% of the portfolio
- Renaissance Technologies (Renaissance Technologies): $177K, 0.0% of the portfolio
Largest institutional holders of LPCN
- Squadron Capital Management LLC — $2.07M
- VANGUARD GROUP INC — $1.78M
- Ikarian Capital, LLC — $1.30M
- Eversept Partners, LP — $755K
- VANGUARD CAPITAL MANAGEMENT LLC — $591K
- ACADIAN ASSET MANAGEMENT LLC — $435K
- BOOTHBAY FUND MANAGEMENT, LLC — $360K
- JANE STREET GROUP, LLC — $244K
- BlackRock, Inc. (BLK) — $229K
- TWO SIGMA INVESTMENTS, LP — $217K
Recent LPCN insider trades
- Sep 30, 2026: Higuchi John W. bought 25,007 shares ($55.0K)
- Sep 28, 2026: Higuchi John W. bought 12,561 shares ($27.1K)
- Apr 7, 2026: Higuchi John W. bought 40,000 shares ($81.2K)
- Apr 6, 2026: Higuchi John W. bought 123,000 shares ($252K)
5%+ owners
- Squadron Master Fund LP: 9.8% (Schedule 13G/A, filed Aug 14, 2026)